<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HE11A32D7A43B45AB87BFD6F37C4C1EDE" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 3807 IH: Medical Device Shortage Reduction Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-06-05</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3807</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230605">June 5, 2023</action-date><action-desc><sponsor name-id="C001066">Ms. Castor of Florida</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act with respect to device shortage notifications.</official-title></form><legis-body id="H08815EFD2921406BB455B726EB90733C" style="OLC"><section id="H543119D8E3444681B419085BCB6338C6" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medical Device Shortage Reduction Act of 2023</short-title></quote>. </text></section><section id="HC0FBBE24BB72490B8AD885624CCBFF00"><enum>2.</enum><header>Clarifying device shortage notifications</header><text display-inline="no-display-inline">Section 506J(a) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/356j">21 U.S.C. 356j(a)</external-xref>) is amended—</text><paragraph id="H93EDBCE12AE2450CA2C4396DA1D9F816"><enum>(1)</enum><text>in paragraph (2), by striking <quote>during, or in advance of, a public health emergency</quote>; and</text></paragraph><paragraph id="HE237CC23DD2246EAB4CC391A797A2120"><enum>(2)</enum><text>in the matter following paragraph (2), by striking <quote>, during, or in advance of, a public health emergency declared by the Secretary under section 319 of the Public Health Service Act,</quote>.</text></paragraph></section><section id="H4661D428E9CA4241BAD089F9A07C0BF7"><enum>3.</enum><header>Supply chain risk management</header><subsection id="HCA3078EE88C344429700FB91625595E6"><enum>(a)</enum><text>Section 506J of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/356j">21 U.S.C. 356j</external-xref>) is amended by striking subsection (h) and inserting the following:</text><quoted-block id="H866BA184CE974CCCB676ED16E4A7D73F" style="OLC"><subsection id="H786B1F91CD8149879B87655DFBB82DC0"><enum>(h)</enum><header>Risk management plans</header><text>Each manufacturer of a device described in subsection (a) shall develop, maintain, and, as appropriate, implement a risk management plan that identifies and evaluates risks to the supply of the device, as applicable, for each establishment in which such device is manufactured. Such risk management plan—</text><paragraph id="H0E64EE5E6F4B4B4D848E20675E8C61CD"><enum>(1)</enum><text>may identify and evaluate risks to the supply of more than 1 device, or device category, manufactured at the same establishment; and</text></paragraph><paragraph id="H8F7648BAC6CF479E953FF1BC1DE9158F"><enum>(2)</enum><text>shall be subject to inspection and copying by the Secretary pursuant to section 704 or at the request of the Secretary.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H30EE231893264249BCC94696690F9298"><enum>(b)</enum><header>Conforming amendment</header><text>Section 506J(f) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/356j">21 U.S.C. 356j(f)</external-xref>) is amended by striking <quote>or (h)</quote> after <quote>subsection (a)</quote>.</text></subsection></section><section id="HEA2007CE02824AE7843A3A62B12CF7CB"><enum>4.</enum><header>Clarifying voluntary notifications</header><text display-inline="no-display-inline">Section 506J(i) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/356j">21 U.S.C. 356j(i)</external-xref>) is amended by adding at the end the following: <quote>Nothing in this section shall be construed to limit the authority of the Secretary to request that a manufacturer (or other person involved in the device supply chain) provide, on a voluntary basis, information to the Secretary or the authority of the Secretary to receive such information.</quote>.</text></section></legis-body></bill> 

